Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 37Unknown 19Withdrawn 5Recruiting 5Terminated 3Active not recruiting 3Not yet recruiting 2Suspended 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 8Thoracic 5CNS 5Sarcoma 4Gynecologic 4Breast 3Lymphoid 2Head & Neck 2Genitourinary 1

Conditions

Breast Neoplasms 3Radiation Injuries 1Breast Carcinoma In Situ 1

Interventions

Trastuzumab 87Cyclophosphamide 67Capecitabine 67Paclitaxel 64Docetaxel 58Fulvestrant 52Letrozole 50Carboplatin 42pembrolizumab 41Lapatinib 38Doxorubicin 36Anastrozole 32Vinorelbine 31Bevacizumab 31exemestane 28Tamoxifen 25Gemcitabine 25Albumin-Bound Paclitaxel 25Radiotherapy 21Taxes 19atezolizumab 18pertuzumab 17Everolimus 17130-nm albumin-bound paclitaxel 17Epirubicin 16palbociclib 15Magnetic Resonance Spectroscopy 15eribulin 14Ado-Trastuzumab Emtansine 14Goserelin 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Chemotherapy, Adjuvant × Breast × Clear all
NCT00296010 2021-02-23

CASA

ETOP IBCSG Partners Foundation

Phase 3 Terminated
77 enrolled
Breast

Breast Neoplasms

NCT00053911 2014-12-16

Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer

UNICANCER

Phase 3 Terminated
Breast

Breast Neoplasms

NCT00902668 2013-06-20

Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer

Virginia Commonwealth University

Phase 2 Terminated
3 enrolled 4 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡